IRIS
COLUSSI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.042
AS - Asia 5.769
EU - Europa 4.228
SA - Sud America 1.085
Continente sconosciuto - Info sul continente non disponibili 611
AF - Africa 121
OC - Oceania 9
Totale 24.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.868
SG - Singapore 2.836
CN - Cina 1.154
UA - Ucraina 1.129
IT - Italia 886
BR - Brasile 846
HK - Hong Kong 610
DE - Germania 567
FI - Finlandia 432
VN - Vietnam 350
RU - Federazione Russa 292
FR - Francia 262
IE - Irlanda 201
TR - Turchia 164
IN - India 152
SE - Svezia 125
GB - Regno Unito 122
BD - Bangladesh 117
AR - Argentina 100
CA - Canada 92
KR - Corea 70
IQ - Iraq 53
MX - Messico 49
JP - Giappone 39
NL - Olanda 39
PK - Pakistan 37
CO - Colombia 36
EC - Ecuador 30
ZA - Sudafrica 29
BE - Belgio 28
PL - Polonia 26
UZ - Uzbekistan 25
ID - Indonesia 24
AT - Austria 23
MA - Marocco 22
VE - Venezuela 22
ES - Italia 21
EU - Europa 19
IR - Iran 18
SA - Arabia Saudita 18
EG - Egitto 16
CZ - Repubblica Ceca 15
LB - Libano 15
JO - Giordania 14
PE - Perù 14
CL - Cile 13
KE - Kenya 13
DZ - Algeria 9
PY - Paraguay 9
TN - Tunisia 9
CH - Svizzera 8
MY - Malesia 8
OM - Oman 8
AU - Australia 7
BO - Bolivia 7
UY - Uruguay 7
EE - Estonia 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CR - Costa Rica 5
HN - Honduras 5
JM - Giamaica 5
NP - Nepal 5
RS - Serbia 5
IL - Israele 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TG - Togo 4
TT - Trinidad e Tobago 4
AL - Albania 3
BW - Botswana 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
PA - Panama 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BT - Bhutan 2
BZ - Belize 2
CM - Camerun 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
ME - Montenegro 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 24.247
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.428
Singapore 1.195
Fairfield 1.110
Ashburn 936
Ann Arbor 912
Jacksonville 798
San Jose 612
Hong Kong 608
Chandler 594
Houston 583
Beijing 544
Dearborn 501
Wilmington 496
Seattle 456
Cambridge 370
Boardman 293
Council Bluffs 219
Princeton 218
Dublin 198
Lauterbourg 197
Los Angeles 166
Udine 150
Buffalo 110
Izmir 109
Dallas 105
Hefei 91
Ho Chi Minh City 88
San Diego 84
Hanoi 82
Helsinki 75
São Paulo 67
New York 66
Santa Clara 65
Seoul 60
Redondo Beach 59
The Dalles 58
Des Moines 50
Milan 50
Munich 50
Ogden 48
Dong Ket 47
Norwalk 44
Redmond 42
Ottawa 40
Rome 38
Nanjing 37
Tokyo 37
Orem 36
Mumbai 35
Frankfurt am Main 33
San Mateo 32
Kunming 30
Rio de Janeiro 29
Nuremberg 28
Atlanta 26
Baghdad 26
Brussels 26
Guangzhou 26
Phoenix 24
Warsaw 24
Pittsburgh 23
Belo Horizonte 22
Brooklyn 21
London 21
Johannesburg 20
Tashkent 20
Amsterdam 19
Ankara 19
Trieste 19
Chennai 18
Dhaka 18
Shanghai 18
Chicago 17
Denver 17
San Francisco 17
Stockholm 17
Manchester 16
Montreal 15
Boston 14
Goiânia 14
Vienna 14
Mcallen 13
New Delhi 13
Amman 12
Brasília 12
Brno 12
Grafing 12
Jinan 12
Nairobi 12
Poplar 12
Porto Alegre 12
Quito 12
Cairo 11
Da Nang 11
Falls Church 11
Fortaleza 11
Mexico City 11
Toronto 11
Turku 11
Washington 11
Totale 15.162
Salva come PNG Salva come JPEG
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 270
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 244
Aldosterone and the heart: from basic research to clinical evidence 208
Aldosterone and Left Ventricular Remodeling 200
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 187
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 182
Aldosterone and the heart: still an unresolved issue? 181
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 180
Aldosterone, Organ Damage, and Dietary Salt 174
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 174
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 172
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 171
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 168
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 167
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 166
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 162
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 162
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 161
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 161
Diabetes, diabetic complications, and blood pressure targets 160
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 160
Treatment of primary aldosteronism and organ protection 158
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 157
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 157
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 157
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 156
The emergent cardiovascular risk factors and organ damage in arterial hypertension 155
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 154
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 152
Cardiovascular outcomes in patients with primary aldosteronism after treatment 152
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 151
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 150
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 150
Salt, hypertension, and cardiovascular disease 149
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 147
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 147
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 147
Benzodiazepines: an old class of new antihypertensive drugs? 146
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 146
Renal function in primary aldosteronism 144
Potassium-sparing diuretics in hypertension 141
Kidney in primary aldosteronism: a key determinant of treatment outcome 141
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 141
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 140
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 137
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 136
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 136
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 134
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 134
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 134
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 133
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 132
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 132
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 130
Endothelial function in patients with non-alcoholic fatty liver disease 129
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 129
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 129
Hypertension and type 2 diabetes: lights and shadows about causality 129
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 128
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 128
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 128
Uricaemia and left ventricular mass in hypertensive patients 127
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 127
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 127
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 127
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 126
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 126
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 126
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 125
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 125
RELATIONSHIPS BETWEEN NAFLD BIOCHEMICAL SCORES AND LEFT VENTRICULAR GEOMETRIC PATTERN IN NAÏVE ESSENTIAL HYPERTENSIVE PATIENTS 124
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 124
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 124
Renal function in primary aldosteronism: revisiting the concept of “renin escape” 124
Abnormal 24-hour blood pressure profile and left ventricular geometry in patients with myotonic dystrophy 123
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 122
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 121
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 121
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 121
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 120
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 120
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 120
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 119
Cardiac and renal damage in primary aldosteronism 118
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 118
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 117
Reversal of left ventricular hypertrophy after treatment is related to severity of disease in patients with primary aldosteronism 116
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 116
. L’attività fisica migliora la sensibilità all’insulina ed i fattori di rischio protrombotico in una popolazione di pazienti ipertesi 115
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 114
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 114
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 113
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 113
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 113
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 113
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 112
Renal and cardiovascular outcomes in renal revascularization in patients with resistant hypertension. 111
Hyperaldosteronism and Left Ventricular Hypertrophy 110
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 109
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 109
Totale 14.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20253.580 80 265 141 116 72 155 173 186 415 294 638 1.045
2025/20266.972 476 714 543 601 1.065 557 955 225 542 600 442 252
2026/202798 98 0 0 0 0 0 0 0 0 0 0 0
Totale 24.865